High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. (1st October 2019) - Blanchard, S.K.; Sullivan, K.M.; Hooten, J.N.; Holcomb, Z. E.; Rowe Nichols, K.; Selim, M.A.; Rao, C.L.; Hall, R.P.; Chao, N.J.; Cardones, A.R.